相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclosporine Inhibition of Hepatic and Intestinal CYP3A4, Uptake and Efflux Transporters: Application of PBPK Modeling in the Assessment of Drug-Drug Interaction Potential
Michael Gertz et al.
PHARMACEUTICAL RESEARCH (2013)
A Physiologically Based Pharmacokinetic Model for Strontium Exposure in Rat
Henry Pertinez et al.
PHARMACEUTICAL RESEARCH (2013)
Application of a Physiologically Based Pharmacokinetic Model to Assess Propofol Hepatic and Renal Glucuronidation in Isolation: Utility of In Vitro and In Vivo Data
Katherine L. Gill et al.
DRUG METABOLISM AND DISPOSITION (2013)
Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
A. Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model
Leonid Gibiansky et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
Applications of minimal physiologically-based pharmacokinetic models
Yanguang Cao et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution
Adam S. Darwich et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Malcolm Rowland et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review
P. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Physiologically Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Sara K. Quinney et al.
DRUG METABOLISM AND DISPOSITION (2010)
A Bayesian population PBPK model for multiroute chloroform exposure
Yuching Yang et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2010)
Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models
Sabine Pilari et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals
Frederic Y. Bois et al.
TOXICOLOGY (2010)
A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of 'Bottom-Up' vs 'Top-Down' Recognition of Covariates
Masoud Jamei et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
A method for robust model order reduction in pharmacokinetics
Aristides Dokoumetzidis et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2009)
Physiologically Based Pharmacokinetic Modeling to Predict Transporter-Mediated Clearance and Distribution of Pravastatin in Humans
Takao Watanabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles
Sheila Annie Peters
CLINICAL PHARMACOKINETICS (2008)
Methods for Predicting In Vivo Pharmacokinetics Using Data from In Vitro Assays
J. Brian Houston et al.
CURRENT DRUG METABOLISM (2008)
Approaches for applications of physiologically based pharmacokinetic models in risk assessment
Chad M. Thompson et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2008)
Data-based identifiability analysis of non-linear dynamical models
S. Hengl et al.
BIOINFORMATICS (2007)
Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM
Grant Langdon et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Amin Rostami-Hodjegan et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Whole-body physiologically based pharmacokinetic models
Ivan Nestorov
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA
Jiansong Yang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs
Ivelina Gueorguieva et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Structural identifiability of physiologically based pharmacokinetic models
JWT Yates
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Optimal design for multivariate response pharmacokinetic models
I Gueorguieva et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: Diazepam case study
I Gueorguieva et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Lumping in pharmacokinetics
C Brochot et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2005)
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
S Björkman
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
T Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding
XR Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Population pharmacokinetics II: Estimation methods
EI Ette et al.
ANNALS OF PHARMACOTHERAPY (2004)
Whole body pharmacokinetic models
I Nestorov
CLINICAL PHARMACOKINETICS (2003)
Use of prior information to stabilize a population data analysis
PO Gisleskog et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2002)
Assessing the reliability of PBPK models using data from methyl chloride-exposed, non-conjugating human subjects
F Jonsson et al.
ARCHIVES OF TOXICOLOGY (2001)
Modelling and simulation of variability and uncertainty in toxicokinetics and pharmacokinetics
I Nestorov
TOXICOLOGY LETTERS (2001)
Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics
FY Bois
ENVIRONMENTAL HEALTH PERSPECTIVES (2000)
分享论文
